Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06876805

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

The Role of Contrast Enhanced Ultrasond (Ceus), in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the study is to determine the accuracy of CEUS in characterizing (as benign or malignant) focal liver lesions for which CT, MRI and/or PET have not been conclusive.

Detailed description

The study conducted will be a non-profit, observational, non-pharmacological, cross-sectional, but also partly cohort, retrospective and prospective study. The study is cross-sectional in nature, but will require 6 months of follow-up to evaluate the gold standard reference outcome in patients diagnosed with a benign pathology that does not require further investigations, and in patients with suspected malignant lesion for which histological diagnosis has not been performed on biopsy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCEUS or Contrast enhanced UltrasoundCEUS performed as normal clinical practice

Timeline

Start date
2024-08-01
Primary completion
2026-08-01
Completion
2027-04-01
First posted
2025-03-14
Last updated
2025-03-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06876805. Inclusion in this directory is not an endorsement.

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods (NCT06876805) · Clinical Trials Directory